Valion Bio VBIO
NASDAQ VBIO
$0.12 +0.00 (+0.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Depreciation & Amortization (CF) (2021 - 2026)

Valion Bio (VBIO) posted quarterly Depreciation & Amortization (CF) of $3000.0 for Q4 2025, up 200.0% quarter-over-quarter from $1000.0 in Q2 2025.

Valion Bio (VBIO) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Valion Bio's Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $3000.0 for Q4 2025.

  • In Q4 2025, Depreciation & Amortization (CF) changed N/A year-over-year to $3000.0; the TTM figure through Dec 2025 stood at $5000.0 (up 66.67% YoY), while the FY2025 annual figure was $5000.0, up 66.67% from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 stood at $3000.0, up from $1000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $3000.0 in Q3 2022, with the low at $1000.0 in Q3 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $2000.0 (2021), against an average of $1888.9.
  • The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) soared 50.0% in 2022, then sank 66.67% in 2023.
  • Valion Bio's Depreciation & Amortization (CF) stood at $2000.0 in 2021, then jumped by 50.0% to $3000.0 in 2022, then plunged by 33.33% to $2000.0 in 2023, then slumped by 50.0% to $1000.0 in 2024, then surged by 200.0% to $3000.0 in 2025.
  • Business Quant data shows VBIO's Depreciation & Amortization (CF) at $3000.0 in Q4 2025, $1000.0 in Q2 2025, and $1000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 40.52 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 191.83 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Valion Bio 405,599.63 -1.79 Mn -45,000.00 -

Historic Data

Download Data
DateValue
Jun 30, 2026 358,000.00
Jun 30, 2026 358,000.00
Dec 31, 2025 3,000.00
Dec 31, 2025 3,000.00
Jun 30, 2025 1,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 1,000.00
Mar 31, 2025 1,000.00
Sep 30, 2024 1,000.00
Sep 30, 2024 1,000.00
Jun 30, 2024 1,000.00
Jun 30, 2024 1,000.00
Mar 31, 2024 1,000.00
Mar 31, 2024 1,000.00
Dec 31, 2023 2,000.00
Dec 31, 2023 2,000.00
Sep 30, 2023 1,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 3,000.00
Jun 30, 2023 3,000.00